ADMA icon

ADMA Biologics

52 hedge funds and large institutions have $58M invested in ADMA Biologics in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

42% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 12

65% less capital invested

Capital invested by funds: $165M → $58M (-$107M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
52
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2K
Puts
$2K
Net Calls
Net Calls Change

Top Sellers

1 -$1.28M
2 -$1.17M
3 -$664K
4
BC
Broadfin Capital
New York
-$568K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$479K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$14.5M
2
$11M
3
$10.1M
4
$8.62M
5
$3.17M
6
$2.31M
7
$1.92M
8
$956K
9
$838K
10
$743K
11
$661K
12
$563K
13
$435K
14
$291K
15
$160K
16
$156K
17
$154K
18
$131K
19
$120K
20
$120K
21
$105K
22
$89K
23
$74K
24
$72K
25
$64K